How prescription drugs in transition out of marketing dilemma.docVIP

How prescription drugs in transition out of marketing dilemma.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
How prescription drugs in transition out of marketing dilemma

 PAGE \* MERGEFORMAT 26 How prescription drugs in transition out of marketing dilemma In 2002 for the prescription drug businesses, is an unusual year, GMP certification, drug bidding system, as well as on a larger scale than ever before, the acquisition of capital intensified after several years of deliberation, prescription drugs era of corporate consolidation has come for all pharmaceutical companies have had a painful transformation. In this context, we will be the domestic prescription drug business results of the analysis mode of operation of the assembly written in order to transition to the marketing dilemma in the domestic pharmaceutical companies to provide some ideas. The first part of the operational characteristics of the domestic pharmaceutical companies sales model 1, sales patterns of birth defects 1, imitation products, the lack of originality advantage: all along, the domestic pharmaceutical companies in drug research and development are taken by way of imitation, chemical, medicine for more than 95% were generic products, no patents, and the resulting lack of drugs is unique, in the products can play the contents of the very short; While generics have their development potential, but the structure of the domestic pharmaceutical market is too single, in fact, Chinese medicine research capability is not weak, but bad business transformation capabilities. 2, repeated construction, over-supply: Domestic pharmaceutical companies up to more than 6,000, most are based on chemical-based pharmaceutical manufacturer, the lack of proprietary technology, the manufacturers have basically made an issue in the 3,4-type drugs on the market rushed and are identical on the product, the formation of duplicate construction situation, in which supply exceeds demand, the pharmaceutical companies use in order to survive with a gold sales. 3, free medical service, fee competition: public health as an important labor system is a product of the planned economy e

文档评论(0)

hhuiws1482 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档